Tiny Health - What Sets Us Apart

Hi, I'm Cheryl Suhoy, Founder and CEO of Tiny Health. This journey started when my daughter developed eczema and food sensitivities. I tried everything but nothing worked until I looked into her gut. That personal experience led me to build Tiny Health, the first precision microbiome platform focused on prevention from the first 1000 days and now across the entire lifespan. We use shotgun metagenomic sequencing, the gold standard in microbiome science, and build our own AI powered biometics engine. We detect over 120,000 microbes at the stream and functional level, delivering clinical read insights that help families and practitioners act before symptoms emerge. What sets us apart? We started at the beginning, early life and built upward. That gives us a rare view of gut development, disease risk and resilience. Today, over 80,000 people and 2,000 healthcare practitioners use Tiny Health to support everything from eczema and IBS to metabolic health and longevity. Our clinical trial in infants showed 76% of babies improved gut health and 60% saw symptom relief with an average of $22,000 in annual healthcare savings per family. And we're continuing to build the clinical evidence with multiple IRB approved studies. While we begin in pediatrics, our biggest growth today is in adult health and wellness. Nearly 70% of U.S. adults live with at least one chronic condition and our platform helps extend not just lifespan but also health span. Through our part by tiny B2B model, we're helping health systems, clinics and wellness brands deliver microbiome based care at scale. We're not just another gut test, we're shaping the future of preventative health at every stage of life. Thank you.